Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Grever

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Leukemia Research|May 5, 2001
Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemiaJ K Waselenko, M R Grever, C A Shinn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1983
Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosineM R Grever, M F Siaw, M S Coleman, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1982
Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemiaS P Balcerzak, M R Grever, D E Sing, et al.
Journal of the American Academy of Dermatology|May 13, 1999
Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune diseaseH C Nousari, R A Brodsky, R J Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasisG W Wortmann, N E Aronson, J C Byrd, et al.
Cancer Treatment Reports|February 1, 1982
2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemiaD P Gray, M R Grever, M F Siaw, et al.
Cancer Treatment Reports|November 1, 1979
Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibitionC A Koller, B S Mitchell, M R Grever, et al.
Cancer Research|July 15, 1994
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosoureaJ Plowman, W R Waud, A D Koutsoukos, et al.
Cancer Research|October 10, 1998
Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitorR Z Orlowski, J R Eswara, A Lafond-Walker, et al.
Cancer Research|May 15, 1987
Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activityJ M Leiby, K M Snider, E H Kraut, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Leukemia Research|May 5, 2001
Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemiaJ K Waselenko, M R Grever, C A Shinn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1983
Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosineM R Grever, M F Siaw, M S Coleman, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1982
Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemiaS P Balcerzak, M R Grever, D E Sing, et al.
Journal of the American Academy of Dermatology|May 13, 1999
Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune diseaseH C Nousari, R A Brodsky, R J Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasisG W Wortmann, N E Aronson, J C Byrd, et al.
Cancer Treatment Reports|February 1, 1982
2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemiaD P Gray, M R Grever, M F Siaw, et al.
Cancer Treatment Reports|November 1, 1979
Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibitionC A Koller, B S Mitchell, M R Grever, et al.
Cancer Research|July 15, 1994
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosoureaJ Plowman, W R Waud, A D Koutsoukos, et al.
Cancer Research|October 10, 1998
Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitorR Z Orlowski, J R Eswara, A Lafond-Walker, et al.
Cancer Research|May 15, 1987
Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activityJ M Leiby, K M Snider, E H Kraut, et al.
Pageof 10